Selected research
Industry Research
Nucleic Acid Nanotechnology Industry Research Report 2026
Market perspective
The global Nucleic Acid Nanotechnology market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nucleic Acid Nanotechnology market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nucleic Acid Nanotechnology market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nucleic Acid Nanotechnology market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nucleic Acid Nanotechnology include GATTAQUANT GMBH, NuProbe, Genisphere, Nanovery, Esya Labs, Nomic,, Torus Biosystems, NanoApps Medical, Inc. and Creative Biolabs and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nucleic Acid Nanotechnology market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nucleic Acid Nanotechnology.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nucleic Acid Nanotechnology Market by Company
GATTAQUANT GMBH
NuProbe
Genisphere
Nanovery
Esya Labs
Nomic,
Torus Biosystems
NanoApps Medical, Inc.
Creative Biolabs
tilibit nanosystems
Nucleic Acid Nanotechnology Segment by Type
DNA Nanotechnology
RNA Nanotechnology
Nucleic Acid Nanotechnology Segment by Application
Drug Delivery Systems
Biosensors
Nanorobotics
Other
Nucleic Acid Nanotechnology Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nucleic Acid Nanotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nucleic Acid Nanotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nucleic Acid Nanotechnology.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nucleic Acid Nanotechnology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Nanotechnology
- RNA Nanotechnology
Applications
- Drug Delivery Systems
- Biosensors
- Nanorobotics
- Other
Companies covered
- GATTAQUANT GMBH
- NuProbe
- Genisphere
- Nanovery
- Esya Labs
- Nomic,
- Torus Biosystems
- NanoApps Medical, Inc.
- Creative Biolabs
- tilibit nanosystems
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nucleic Acid Nanotechnology by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 DNA Nanotechnology
- 2.2.3 RNA Nanotechnology
- 2.3 Nucleic Acid Nanotechnology by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Delivery Systems
- 2.3.3 Biosensors
- 2.3.4 Nanorobotics
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Nucleic Acid Nanotechnology Breakdown Data by Type
- 3.1 Global Nucleic Acid Nanotechnology Historic Market Size by Type (2021-2026)
- 3.2 Global Nucleic Acid Nanotechnology Forecasted Market Size by Type (2027-2032)
4 Nucleic Acid Nanotechnology Breakdown Data by Application
- 4.1 Global Nucleic Acid Nanotechnology Historic Market Size by Application (2021-2026)
- 4.2 Global Nucleic Acid Nanotechnology Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nucleic Acid Nanotechnology Market Perspective (2021-2032)
- 5.2 Global Nucleic Acid Nanotechnology Growth Trends by Region
- 5.2.1 Global Nucleic Acid Nanotechnology Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nucleic Acid Nanotechnology Historic Market Size by Region (2021-2026)
- 5.2.3 Nucleic Acid Nanotechnology Forecasted Market Size by Region (2027-2032)
- 5.3 Nucleic Acid Nanotechnology Market Dynamics
- 5.3.1 Nucleic Acid Nanotechnology Industry Trends
- 5.3.2 Nucleic Acid Nanotechnology Market Drivers
- 5.3.3 Nucleic Acid Nanotechnology Market Challenges
- 5.3.4 Nucleic Acid Nanotechnology Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nucleic Acid Nanotechnology Players by Revenue
- 6.1.1 Global Top Nucleic Acid Nanotechnology Players by Revenue (2021-2026)
- 6.1.2 Global Nucleic Acid Nanotechnology Revenue Market Share by Players (2021-2026)
- 6.2 Global Nucleic Acid Nanotechnology Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nucleic Acid Nanotechnology Head Office and Area Served
- 6.4 Global Nucleic Acid Nanotechnology Players, Product Type & Application
- 6.5 Global Nucleic Acid Nanotechnology Manufacturers Established Date
- 6.6 Global Nucleic Acid Nanotechnology Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nucleic Acid Nanotechnology Market Size (2021-2032)
- 7.2 North America Nucleic Acid Nanotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nucleic Acid Nanotechnology Market Size by Country (2021-2026)
- 7.4 North America Nucleic Acid Nanotechnology Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nucleic Acid Nanotechnology Market Size (2021-2032)
- 8.2 Europe Nucleic Acid Nanotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nucleic Acid Nanotechnology Market Size by Country (2021-2026)
- 8.4 Europe Nucleic Acid Nanotechnology Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nucleic Acid Nanotechnology Market Size (2021-2032)
- 9.2 Asia-Pacific Nucleic Acid Nanotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nucleic Acid Nanotechnology Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nucleic Acid Nanotechnology Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nucleic Acid Nanotechnology Market Size (2021-2032)
- 10.2 South America Nucleic Acid Nanotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nucleic Acid Nanotechnology Market Size by Country (2021-2026)
- 10.4 South America Nucleic Acid Nanotechnology Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nucleic Acid Nanotechnology Market Size (2021-2032)
- 11.2 Middle East & Africa Nucleic Acid Nanotechnology Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nucleic Acid Nanotechnology Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nucleic Acid Nanotechnology Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 GATTAQUANT GMBH
- 12.1.1 GATTAQUANT GMBH Company Information
- 12.1.2 GATTAQUANT GMBH Business Overview
- 12.1.3 GATTAQUANT GMBH Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.1.4 GATTAQUANT GMBH Nucleic Acid Nanotechnology Product Portfolio
- 12.1.5 GATTAQUANT GMBH Recent Developments
- 12.2 NuProbe
- 12.2.1 NuProbe Company Information
- 12.2.2 NuProbe Business Overview
- 12.2.3 NuProbe Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.2.4 NuProbe Nucleic Acid Nanotechnology Product Portfolio
- 12.2.5 NuProbe Recent Developments
- 12.3 Genisphere
- 12.3.1 Genisphere Company Information
- 12.3.2 Genisphere Business Overview
- 12.3.3 Genisphere Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.3.4 Genisphere Nucleic Acid Nanotechnology Product Portfolio
- 12.3.5 Genisphere Recent Developments
- 12.4 Nanovery
- 12.4.1 Nanovery Company Information
- 12.4.2 Nanovery Business Overview
- 12.4.3 Nanovery Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.4.4 Nanovery Nucleic Acid Nanotechnology Product Portfolio
- 12.4.5 Nanovery Recent Developments
- 12.5 Esya Labs
- 12.5.1 Esya Labs Company Information
- 12.5.2 Esya Labs Business Overview
- 12.5.3 Esya Labs Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.5.4 Esya Labs Nucleic Acid Nanotechnology Product Portfolio
- 12.5.5 Esya Labs Recent Developments
- 12.6 Nomic,
- 12.6.1 Nomic, Company Information
- 12.6.2 Nomic, Business Overview
- 12.6.3 Nomic, Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.6.4 Nomic, Nucleic Acid Nanotechnology Product Portfolio
- 12.6.5 Nomic, Recent Developments
- 12.7 Torus Biosystems
- 12.7.1 Torus Biosystems Company Information
- 12.7.2 Torus Biosystems Business Overview
- 12.7.3 Torus Biosystems Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.7.4 Torus Biosystems Nucleic Acid Nanotechnology Product Portfolio
- 12.7.5 Torus Biosystems Recent Developments
- 12.8 NanoApps Medical, Inc.
- 12.8.1 NanoApps Medical, Inc. Company Information
- 12.8.2 NanoApps Medical, Inc. Business Overview
- 12.8.3 NanoApps Medical, Inc. Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.8.4 NanoApps Medical, Inc. Nucleic Acid Nanotechnology Product Portfolio
- 12.8.5 NanoApps Medical, Inc. Recent Developments
- 12.9 Creative Biolabs
- 12.9.1 Creative Biolabs Company Information
- 12.9.2 Creative Biolabs Business Overview
- 12.9.3 Creative Biolabs Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.9.4 Creative Biolabs Nucleic Acid Nanotechnology Product Portfolio
- 12.9.5 Creative Biolabs Recent Developments
- 12.10 tilibit nanosystems
- 12.10.1 tilibit nanosystems Company Information
- 12.10.2 tilibit nanosystems Business Overview
- 12.10.3 tilibit nanosystems Revenue in Nucleic Acid Nanotechnology Business (2021-2026)
- 12.10.4 tilibit nanosystems Nucleic Acid Nanotechnology Product Portfolio
- 12.10.5 tilibit nanosystems Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst